Biotech & Medtech
Biotech & Medtech news — Friday 09 October 2026
22 stories from 4 sources, every one in English. Each links to its publisher.
-
STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
STAT News
An early advocate for the theory that the Covid-19 virus was engineered in and leaked from a lab in China is no longer the leading choice to be America’s top infectious disease expert, a source with knowledge of the decision told STAT…
-
STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot
STAT News
The American Hospital Association is once again suing the Trump administration over its plan to test revamping a federal drug discount program into one that provides after-the-fact rebates instead of upfront discounts for certain drugs…
-
TRrexBio’s IPO Bags $116M to Bring the Immune System Back Into Balance
MedCity News
Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, Retension Pharmaceuticals will use its IPO…
-
STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds
STAT News
The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing and the number of prescriptions written, likely leading to rising health care costs, according to a Cochrane review of dozens of previous…
-
STAT+: Medicare Advantage star ratings trigger new bonuses, and uncertainty
STAT News
The federal government has released new quality ratings for Medicare Advantage insurers for 2027, with Humana emerging as the biggest winner. But deep uncertainty remains around Medicare Advantage quality measures, which come with tens of…
-
STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. This is the Readout. Please read it. And don’t miss us too much Monday, when the newsletter will be paused for the…
-
FDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts
BioPharma Dive
The new disclosure suggested Rasonque might not be as broadly effective as previously thought. Elsewhere, Ultragenyx got a much-needed cash infusion and TCGX started a China-focused fund.
-
This week in charts: What’s driving biotech’s recent pullback?
BioPharma Dive
The latest installment in BioPharma Dive’s data visualization series features a look at the factors pressuring biotech stocks of late and the frenetic pace of startup buyouts this year.
-
STAT+: Up and down the ladder: The latest comings and goings
STAT News
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them . Don’t be shy…
-
What Life Sciences Commercial Teams Can Learn from Digital Health
MedCity News
The pace of change in digital innovation has exposed the ever-widening gap between digital health and Pharma commercial teams. As a result, Pharma is missing out on its ability to significantly improve its commercial model, by focusing on…
-
How these census changes could threaten public health
STAT News
Hi there, it’s Sarah. Last night, STAT scored an awards hat trick, taking home a Gerald Loeb — the most prestigious honor in business journalism — for the third year in a row! This year’s Loeb recognized Lizzy Lawrence for her exceptional…
-
STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more
STAT News
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to catch up on our reading…
-
TRex Bio prices $117M IPO to support immune drug work
BioPharma Dive
Eli Lilly is the largest equity holder in TRex, which is developing drugs that treat immunological conditions by activating “Treg” cells.
-
The fall of Roe dramatically changed abortion access. This researcher used Reddit to capture how
STAT News
Betsy Pleasants was studying one historic disruption to abortion access when a more seismic one emerged. In spring 2022, as a graduate student at UC Berkeley School of Public Health, Pleasants was researching the effects of the Covid-19…
-
Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionary
STAT News
September marked 50 years since my colleagues and I published a paper describing what became known as interleukin-2, or IL-2, one of the first cytokines to be discovered and a protein essential to the growth and regulation of T cells…
-
Opinion: Proposed U.S. census changes could be catastrophic for public health
STAT News
In 2030, U.S. mortality and morbidity rates will suddenly jump. This will happen not because there is a new pandemic or a sudden rise in cases of existing diseases or injuries, or a sudden decline in access to health care. These jumps in…
-
STAT+: Will MAHA survive the midterms?
STAT News
WASHINGTON — Health secretary Robert F. Kennedy Jr.’s Make America Healthy Again movement rushed into American politics with a promise: Let an unlikely coalition of activists reach the masses, and they will deliver revolutionary gains for…
-
The Red Queen G\"odel Machine: Co-Evolving Agents and Their Evaluators
arXiv cs.NE (Neural／Bio)
arXiv:2606.26294v3 Announce Type: replace-cross Abstract: Self-improving agents are state-of-the-art on agentic coding benchmarks, yet their search methods assume a stationary evaluation criterion. This ignores a central feature of…
-
Universal Construction and Exact Self-Reproduction in Ternary McCulloch-Pitts Networks
arXiv cs.NE (Neural／Bio)
arXiv:2610.12251v1 Announce Type: cross Abstract: A fixed network of McCulloch-Pitts threshold units with weights in {-1,0,1} can hold other threshold networks in its state and run them: the state is a ring of banks of records, each record…
-
Learning to Orchestrate Evolutionary Search: Progression-Aware Deep Reinforcement Learning for Dynamic DE-CMA-ES Coordination in Optimization and Structural Model Updating
arXiv cs.NE (Neural／Bio)
arXiv:2610.11546v1 Announce Type: new Abstract: Solving high-dimensional structural model updating problems requires an algorithm capable of navigating complex, non-convex landscapes with correlated parameters. Existing hybrid evolutionary…
-
A Closer Look at Agentic BBO: Benchmarking LLM Agents for Black-Box Optimization
arXiv cs.NE (Neural／Bio)
arXiv:2610.12183v1 Announce Type: cross Abstract: Black-box optimization (BBO) arises in many scientific and engineering problems where objective evaluations are expensive and limited. Recent large language model (LLM) agents offer a new…
-
BiomedXPro: Prompt Optimization for Explainable Diagnosis with Biomedical Vision Language Models
arXiv cs.NE (Neural／Bio)
arXiv:2510.15866v2 Announce Type: replace-cross Abstract: The clinical adoption of biomedical vision-language models is hindered by prompt optimization techniques that produce either uninterpretable latent vectors or single textual…